Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients

Philippe Gautret (1) , Stéphane Honoré (2) , Jean-Christophe Lagier (3) , Didier Raoult (3, 4)

1 VITROME - Vecteurs - Infections tropicales et méditerranéennes
2 Service Pharmacie [Hôpital de la Timone - APHM]
3 MEPHI - Microbes évolution phylogénie et infections
4 IHU Marseille - Institut Hospitalier Universitaire Méditerranée Infection

Domains: Life Sciences [q-bio]; Microbiology and Parasitology; Bacteriology; Life Sciences [q-bio]; Microbiology and Parasitology; Virology; Life Sciences [q-bio]; Microbiology and Parasitology; Parasitology; Life Sciences [q-bio]; Human health and pathology; Cardiology and cardiovascular system; Life Sciences [q-bio]; Human health and pathology; Emerging diseases; Life Sciences [q-bio]; Human health and pathology; Infectious diseases

Philippe Gautret, Stéphane Honoré, Jean-Christophe Lagier, Didier Raoult. Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients. International Journal of Antimicrobial Agents, 2021, 57 (1), pp.106236. ⟨10.1016/j.ijantimicag.2020.106236⟩. ⟨hal-03215703⟩